Viewing Study NCT06773208


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-01-13 @ 4:29 PM
Study NCT ID: NCT06773208
Status: RECRUITING
Last Update Posted: 2025-08-01
First Post: 2025-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module